Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01917318 · ClinicalTrials.gov registry record · Phase 2
Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)
A Phase 2 study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT01917318: Clinical Trial Phase 2 study, sponsored by University of Colorado, Denver.
NCT01917318 is a Phase 2 study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 1 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01917318, a Phase 2 study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
A Double-Blind Placebo-Controlled Random Order Crossover Pilot Study of Iloperidone for Symptoms of Arousal in PTSD.
Primary Outcome
The Clinician-Administered PTSD Scale (CAPS) is a structured interview used to diagnose and assess PTSD. Part B of CAPS evaluates symptoms of re-experiencing. Part D evaluates avoidance and numbing. CAPS-B scores range from 0 to 40 where higher scores indicate more symptoms. A score 0 means no re-experiencing symptoms. CAPS-D scores range form 0 to 56 and higher scores indicate more symptoms. A score 0 means no avoidance or numbing symptoms. The primary endpoint was changes in CAPS part B and
Interventions
- DRUG Placebo
- DRUG Iloperidone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-07 |
| Est. Completion | 2014-02 |
| Phase | Phase 2 |
Why NCT01917318 stopped before completion
NCT01917318 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01917318 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01917318 about?
NCT01917318 is a clinical study titled "Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)". A Double-Blind Placebo-Controlled Random Order Crossover Pilot Study of Iloperidone for Symptoms of Arousal in PTSD.
What is the current status of trial NCT01917318?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2013-07. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01917318?
The interventions under investigation include: Placebo (DRUG), Iloperidone (DRUG).
Who is sponsoring clinical trial NCT01917318?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01917318's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia